Skip to main content
. 2022 Dec 1;42(6):397-407. doi: 10.5144/0256-4947.2022.397

Table 4.

Gastrointestinal comorbidities in patients with inflammatory bowel disease.

Overall Crohn's disease Ulcerative colitis P value Missing data
Gastrointestinal comorbidities 102 (23.5) 41 (16.5) 61 (32.8) <.0001 0
 Liver disease 35 (8.1) 14 (5.6) 21 (11.3) .0315 0
 Hepatitis 19 (4.4) 7 (2.8) 12 (6.5) .0661 0
 Infectious 34 (7.8) 18 (7.2) 16 (8.6) .5976 0
 Clostridium difficile 11 (2.5) 4 (1.6) 7 (3.8) .2176 0
Helicobacter pylori infection 9 (2.1) 6 (2.4) 3 (1.6) .7385 0
 Intestinal tuberculosis 6 (1.4) 6 (2.4) 0 .0401 0
 Pancreatobiliary (gallbladder, biliary tract and pancreas) 27 (6.2) 9 (3.6) 18 (9.7) .0095 0
 Autoimmune 14 (3.2) 2 (0.8) 12 (6.5) .0014 0
 Celiac 7 (1.6) 1 (0.4) 6 (3.2) .0456 0
 Gastroesophageal reflux disease 13 (3) 4 (1.6) 9 (4.8) .0839 0
 Gastrointestinal malignancy 10 (2.3) 3 (1.2) 7 (3.8) .0192 2
 Irritable bowel syndrome 9 (2.1) 4 (1.6) 5 (2.7) .5060 0
Other gastrointestinal comorbidities 7 (1.6) 4 (1.6) 3 (1.6) .999 0
 Diverticular 4 (1) 3 (1.2) 1 (0.5) .6390 0
 Primary biliary cirrhosis 1 (0.2) 1 (0.4) 0 .999 0

Data are n (%).